Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model  Daniel.

Slides:



Advertisements
Similar presentations
Total arterial revascularization of triple vessel coronary disease based on combined internal thoracic and radial artery grafts  Robert H. Habib, PhD,
Advertisements

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
Right internal thoracic artery or saphenous vein grafting
Which is more important in the potential interference on cardioprotection by remote ischemic preconditioning: β-blockers or anesthetic choice?  Yang Liu,
Juan A. Crestanello, MD, Richard C. Daly, MD 
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Multilevel data analysis: What? Why? How?
Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 
Bicuspid aortic valve aortopathy: One size fits all?
Bigger The Journal of Thoracic and Cardiovascular Surgery
Commentary: Pursuit of the green jacket: Mastery of the long and short games  Daniel P. Raymond, MD  The Journal of Thoracic and Cardiovascular Surgery 
The lord of the rings  Antonio Miceli, MD, PhD 
Jared P. Beller, MD, Irving L. Kron, MD 
Juan N. Pulido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Support Your Specialty
Oh, father, where art we? Left internal mammary artery with greater saphenous vein grafts still rules surgical coronary revascularization after 30 years 
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
For everything there is a season
Do we need a bibliometrician to know which way the wind is blowing?
A first start for lung transplantation?
Get it right the first time
Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc 
Daniel T. Engelman, MD, FACS, Michael J. Germain, MD 
Frank C. Spencer, MD, FACS, pioneering cardiothoracic surgeon
Commentary: Ongoing advancements in the understanding of tricuspid valve dynamics and functional geometry  Daniel J.P. Burns, MD, MPhil  The Journal of.
Commentary: Do the right thing! Ethical versus legal
Shengshou Hu, MD, Xin Yuan, MD, PhD 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
The thoracoabdominal saga and heroes
Sutureless valve implantation: Every detail counts
Prognosis and “granularity”: Building on staging foundations?
Who is your plastic surgeon
Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes  Sitaram M. Emani, MD  The Journal of Thoracic.
Shunt right or left? Decision 2016
T. Brett Reece, MD  The Journal of Thoracic and Cardiovascular Surgery 
Ralph S. Mosca, MD  The Journal of Thoracic and Cardiovascular Surgery 
If airlines can do it, we can too…
Innovation in cardiothoracic surgical training
First nights, the adrenal axis, and steroids
Constantine L. Athanasuleas, MD, FACC 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
The future of cardiac surgery training: A survival guide
Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005  Howard K. Song, MD, PhD, Brian S. Diggs,
Bicuspid aortopathy: Seeing the forest for the trees
Ralph E. Delius, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
“The more things change…”: The challenges ahead
Toward a more rational approach in treating type B aortic dissection
Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know  Harold L. Lazar,
Toll-like receptor 4 inhibition attenuates ischemia-reperfusion injury in rats: Will it work in human beings?  Chadrick E. Denlinger, MD  The Journal.
Managing conflicts of interest
Ryan R. Davies, MD  The Journal of Thoracic and Cardiovascular Surgery 
More than vital: Who bears the burden?
Apples remain apples NO matter what
A large international single-center case-series of coronary artery fistulas in children: When high clinical research standards adopted globally create.
European Society of Thoracic Surgeons preoperative mediastinal staging guidelines: From face validity to external validity  Alessandro Brunelli, MD  The.
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
Did you like Terminator 3 better than Terminator 2
Journal changes and initiatives
Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”
IS local wound infection rate more important than long-term graft patency in coronary artery bypass grafting?  Tomislav Kopjar, MD, PhD, Michael R. Dashwood,
Edward Y. Chan, MD, Michael J. Reardon, MD 
Zone zero thoracic endovascular aortic repair is all about “location, location, location”  Kevin L. Greason, MD  The Journal of Thoracic and Cardiovascular.
Calpain inhibitors: The aspirin of the 21st century?
Commentary: Radial artery and bilateral mammary arteries in coronary artery bypass grafting: How much is too much?  Derrick Y. Tam, MD, Stephen E. Fremes,
Presentation transcript:

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model  Daniel T. Engelman, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 153, Issue 2, Pages 381-384 (February 2017) DOI: 10.1016/j.jtcvs.2016.09.052 Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Daniel T. Engelman, MD The Journal of Thoracic and Cardiovascular Surgery 2017 153, 381-384DOI: (10.1016/j.jtcvs.2016.09.052) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions